Clinical Evaluation of Ropinirole PR/XR Tablet for Adjunctive Therapy to L-Dopa in Subjects With Advanced Parkinson's Disease.
Phase of Trial: Phase III
Latest Information Update: 20 Jan 2017
At a glance
- Drugs Ropinirole (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 14 Apr 2011 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 17 Sep 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 16 Jun 2009 Actual initiation date (1 Mar 2009) added as reported by ClinicalTrials.gov.